Stoke Therapeutics (STOK)
(Delayed Data from NSDQ)
$12.76 USD
-0.10 (-0.78%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $12.77 +0.01 (0.08%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.52 | 0.00% |
Earnings Summary
For their last quarter, Stoke Therapeutics (STOK) reported earnings of -$0.46 per share, beating the Zacks Consensus Estimate of $-0.57 per share. This reflects a positive earnings surprise of 19.30%. Look out for STOK's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.52 per share, reflecting a year-over-year increase of 5.45%.
Earnings History
Price & Consensus
Zacks News for STOK
Urogen Pharma (URGN) Expected to Beat Earnings Estimates: Should You Buy?
STOK: What are Zacks experts saying now?
Zacks Private Portfolio Services